JPMorgan Chase covers Palantir for the first time, gives it a “overweight” rating, and includes it in the catalyst list, optimistic about the commercialization and profit growth of AI
The Block
1h ago
Ai Focus
JPMorgan Chase covers artificial intelligence software company Palantir for the first time, giving it a 'overweight' rating and a target price of $262 on December 26, 2027, and includes it in the list of analysts' key focuses. The bank believes that Palantir performs outstandingly in terms of AI commercialization, revenue growth, and profitability, and that the financial report on November 2 may show results that exceed expectations.
Helpful
No.Help

On October 29th, JPMorgan Chase covered the artificial intelligence software company Palantir for the first time, assigning it a 'Buy' rating and a target price of $262 per share by December 2027, and included it in the list of companies that analysts should pay close attention to.

Analyst Brian Essex believes that companies' focus on AI is shifting from how to deploy the technology to how to obtain actual investment returns. Palantir has already achieved this goal by helping customers transform their business operations, and its growth continues to accelerate.

JPMorgan Chase pointed out that Palantir saw revenue growth of 93% year-on-year in the first quarter, marking the 12th consecutive quarter of increasing growth. After adjustments, the operating profit margin reached 62%, and free cash flow increased by 126% year-on-year. The bank believes that Palantir boasts both rapid growth and strong profitability, and its current valuation is reasonable. Its target price of $262 is based on a forecast of $11.7 billion in free cash flow for 2028, as well as a enterprise value to free cash flow ratio of 55 times.

In addition, JPMorgan Chase has included Palantir on its list of potential positive catalyst events, expressing optimism about the quarterly financial report to be released on November 2nd. Although the bank's forecast for third-quarter performance is generally in line with market expectations, it believes there is still a significant possibility that the actual results will exceed these expectations.

Tip
$0
Like
0
Save
0
Views 26
CoinMeta reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
Google Records Its Largest Single-Day Decline in History; Market Value Evaporates by Approximately $500 Billion at Opening
On the evening of October 29th, Beijing time, after the opening of U.S. stocks, Google experienced a sharp decline, with its loss exceeding 13% at one point, setting a record for the largest single-day drop in history. Its market value decreased by over $500 billion from the close of the previous trading day. Alphabet In its third-quarter financial report, both revenue and profits fell short of expectations, and securities firms have also lowered their target prices.
The Block
·2026-10-29 23:43:59
14
Despite Brent oil prices still being above $110, OPEC + expects to maintain the December oil production target unchanged
According to Reuters, citing sources familiar with the matter, OPEC is expected to maintain its December oil production target at the meeting on November 1st, despite Brent crude prices still exceeding $110 per barrel. The report indicates that disruptions in Middle Eastern supply, Gulf oil-producing countries not meeting their quotas, and geopolitical risk premiums continue to support high oil prices.
Coinpaper
·2026-10-29 23:43:57
14
Eli Lilly's stock price hits a new high, with a cumulative increase of nearly 60% in the past year
On October 29th, Eli Lilly reached a record high of $1,334.24 during trading, representing a year-on-year increase of 59.36%, with a market value of approximately $1.15 trillion. Driven by strong demand for weight loss medications and diabetes treatment drugs, the company's revenue has increased by 49.58% in the past 12 months. Several Wall Street institutions have recently raised their target prices, and Bernstein, RBC Capital, and Cantor Fitzgerald all hold an optimistic outlook on its future performance.
The Block
·2026-10-29 23:43:55
10
Nordic Sem Token Issuance nductor Verifying Bluetooth High Data Throughput Function in Silicon Chips
Nordic Sem Token Issuance nductor indicates that the upcoming Bluetooth High Data Throughput (HDT) feature has been verified through video demonstrations on silicon chips. This feature is expected to be released by the Bluetooth Special Interest Group (Bluetooth SIG) at the end of 2026 and will significantly improve data transmission speeds while maintaining Bluetooth's low power consumption efficiency.
PR Newswire
·2026-10-29 23:43:52
13
IDrive Cloud Backup Reaffirms Its Commitment to Secure and Compliant Data Protection
IDrive indicates that it helps enterprises enhance data security and support regulatory compliance through independent audit controls, internationally recognized security certifications, and comprehensive data protection capabilities. The company claims that its services cover SOC, Type II, ISO / IEC 27001:2022, GDPR, and multiple data privacy frameworks, and also support the backup and recovery needs of regulated industries.
PR Newswire
·2026-10-29 23:33:28
11
View More